SK284584B6 - Tableta s riadeným uvoľňovaním - Google Patents

Tableta s riadeným uvoľňovaním Download PDF

Info

Publication number
SK284584B6
SK284584B6 SK1249-2001A SK12492001A SK284584B6 SK 284584 B6 SK284584 B6 SK 284584B6 SK 12492001 A SK12492001 A SK 12492001A SK 284584 B6 SK284584 B6 SK 284584B6
Authority
SK
Slovakia
Prior art keywords
controlled release
release tablet
tablet according
betahistine
active ingredient
Prior art date
Application number
SK1249-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK12492001A3 (sk
Inventor
Flavio Fabiani
Enrico Frimonti
Mauro Valenti
Original Assignee
Farmaceutici Formenti S. P. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Formenti S. P. A. filed Critical Farmaceutici Formenti S. P. A.
Publication of SK12492001A3 publication Critical patent/SK12492001A3/sk
Publication of SK284584B6 publication Critical patent/SK284584B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1249-2001A 1999-03-05 2000-02-28 Tableta s riadeným uvoľňovaním SK284584B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000454A IT1309591B1 (it) 1999-03-05 1999-03-05 Composizioni a rilascio controllato di betaistina.
PCT/EP2000/001642 WO2000053162A1 (en) 1999-03-05 2000-02-28 Controlled-release compositions of betahistine

Publications (2)

Publication Number Publication Date
SK12492001A3 SK12492001A3 (sk) 2001-12-03
SK284584B6 true SK284584B6 (sk) 2005-07-01

Family

ID=11382165

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1249-2001A SK284584B6 (sk) 1999-03-05 2000-02-28 Tableta s riadeným uvoľňovaním

Country Status (37)

Country Link
EP (1) EP1158963B1 (cs)
JP (1) JP2002538197A (cs)
KR (1) KR20010102498A (cs)
CN (1) CN1165295C (cs)
AR (1) AR029154A1 (cs)
AT (1) ATE231392T1 (cs)
AU (1) AU762532B2 (cs)
BG (1) BG105807A (cs)
BR (1) BR0008739A (cs)
CA (1) CA2364226A1 (cs)
CO (1) CO5170438A1 (cs)
CZ (1) CZ299510B6 (cs)
DE (1) DE60001266T2 (cs)
DK (1) DK1158963T3 (cs)
EE (1) EE200100453A (cs)
ES (1) ES2189739T3 (cs)
GE (1) GEP20033078B (cs)
HK (1) HK1042246B (cs)
HR (1) HRP20010650A2 (cs)
HU (1) HUP0200243A2 (cs)
ID (1) ID30127A (cs)
IL (1) IL145263A0 (cs)
IT (1) IT1309591B1 (cs)
MX (1) MXPA01008893A (cs)
NO (1) NO319135B1 (cs)
NZ (1) NZ513949A (cs)
PE (1) PE20001547A1 (cs)
PL (1) PL196290B1 (cs)
PT (1) PT1158963E (cs)
RU (1) RU2248791C2 (cs)
SI (1) SI1158963T1 (cs)
SK (1) SK284584B6 (cs)
TR (1) TR200102566T2 (cs)
UA (1) UA65652C2 (cs)
WO (1) WO2000053162A1 (cs)
YU (1) YU64001A (cs)
ZA (1) ZA200107318B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1585501A4 (en) * 2003-01-23 2007-04-25 Amorepacific Corp PREPARATIONS OF DELAYED RELEASE AND METHOD OF MANUFACTURING THEREOF
DE60320965D1 (de) 2003-07-04 2008-06-26 Formenti Farmaceutici Spa Betahistinezubereitungen mit kontrollierter Freisetzung
US7728015B2 (en) 2004-04-22 2010-06-01 Mor Research Applications Ltd. Compositions for weight management
WO2005101979A2 (en) 2004-04-22 2005-11-03 Mor Research Applications Ltd. Method of food intake management
JP2008507508A (ja) * 2004-07-22 2008-03-13 株式會社アモーレパシフィック トピラメート徐放性製剤及びその製造方法
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
BRPI0912126A2 (pt) 2008-05-27 2015-11-03 Univ Melbourne método de tratamento de mamíferos com disfunções na trompa de eustáquio
EP2314296A1 (en) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Orally Disintegrating Tablets of Betahistine
EP2491930A1 (en) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmaceutical combination of betahistine and trimetazidine
DE102012105528A1 (de) 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
EP3431078B1 (en) * 2017-07-20 2021-01-20 Intas Pharmaceuticals Limited Non-pulsatile prolonged-release betahistine oral solid compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2397840B1 (cs) * 1977-07-22 1981-03-20 Cherqui Jean
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
US6190591B1 (en) * 1996-10-28 2001-02-20 General Mills, Inc. Embedding and encapsulation of controlled release particles

Also Published As

Publication number Publication date
DE60001266D1 (de) 2003-02-27
EP1158963A1 (en) 2001-12-05
ITMI990454A1 (it) 2000-09-05
EP1158963B1 (en) 2003-01-22
CA2364226A1 (en) 2000-09-14
BR0008739A (pt) 2001-12-26
CN1165295C (zh) 2004-09-08
DE60001266T2 (de) 2003-08-28
NO20014301L (no) 2001-09-04
RU2248791C2 (ru) 2005-03-27
CO5170438A1 (es) 2002-06-27
NZ513949A (en) 2003-10-31
ZA200107318B (en) 2002-09-04
NO319135B1 (no) 2005-06-20
PT1158963E (pt) 2003-06-30
GEP20033078B (en) 2003-10-27
IL145263A0 (en) 2002-06-30
HRP20010650A2 (en) 2002-10-31
CN1342069A (zh) 2002-03-27
IT1309591B1 (it) 2002-01-24
PL196290B1 (pl) 2007-12-31
BG105807A (bg) 2002-03-29
WO2000053162A1 (en) 2000-09-14
CZ20013186A3 (cs) 2002-02-13
MXPA01008893A (es) 2002-10-23
PL350232A1 (en) 2002-11-18
JP2002538197A (ja) 2002-11-12
HUP0200243A2 (en) 2002-06-29
CZ299510B6 (cs) 2008-08-20
ID30127A (id) 2001-11-08
YU64001A (sh) 2004-05-12
SI1158963T1 (en) 2003-04-30
ES2189739T3 (es) 2003-07-16
ATE231392T1 (de) 2003-02-15
AU3283100A (en) 2000-09-28
UA65652C2 (uk) 2004-04-15
NO20014301D0 (no) 2001-09-04
TR200102566T2 (tr) 2002-01-21
EE200100453A (et) 2002-12-16
HK1042246A1 (en) 2002-08-09
AR029154A1 (es) 2003-06-18
DK1158963T3 (da) 2003-04-28
HK1042246B (zh) 2005-06-03
AU762532B2 (en) 2003-06-26
SK12492001A3 (sk) 2001-12-03
PE20001547A1 (es) 2001-01-29
KR20010102498A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
EP3078369B1 (en) Coated tablet formulation and method
KR100574207B1 (ko) 하나 이상의 활성 물질의 즉각적 및 장기적 방출을 위한정제
KR101234940B1 (ko) 안정한 서방출형의 경구 투여용 조성물
SK281441B6 (sk) Použitie 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzotiazolu
SK12492001A3 (sk) Tableta s riadeným uvoľňovaním
US20240415777A1 (en) Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
SK121098A3 (en) Slow-release pharmaceutical formulations containing mizolastin
EP2559431A1 (en) Pharmaceutical composition comprising 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
WO2011000518A1 (en) Pharmaceutical composition comprising desloratadine
CA3094550C (en) Instant release pharmaceutical preparations of vicagrel and preparation methods therefor
PL194595B1 (pl) Preparat tiagabiny o przedłużonym uwalnianiu orazjego zastosowanie
HK40038394A (en) Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
KR20090104785A (ko) 안정한 서방출형의 경구 투여용 조성물
HK1228248B (en) Coated tablet formulation and method